[1] Törner A, Stokkeland K, Svensson Å, Dickman P W, Hultcrantz R, Montgomery S, Duberg A-S.The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence[J]. Hepatology, 2017, 65(3):885-892.
[2] Farvardin S, Patel J, Khambaty M, Yerokun O A, Mok H, Tiro J A, Yopp A C, Parikh N D, Marrero J A, Singal A G. Patient-reported barriers are associated with lower HCC surveillance rates in patients with cirrhosis[J]. Hepatology, 2017, 65(3):875-884.
[3] Carrafiello G, Laganà D, Mangini M, Fontana F, Dionigi G, Boni L, F Roverac, S Cuffarib, C Fugazzola. Microwave tumors ablation:principles, clinical applications and review of preliminary experiences[J]. International Journal of Surgery, 2008, 6(Suppl 1):S65-S69.
[4] Chu K F, Dupuy D E. Thermal ablation of tumours:biological mechanisms and advances in therapy[J]. Nature Reviews Cancer, 2014, 14(3):199-208.
[5] Wolf F J, Grand D J, Machan J T, Dipetrillo T A, Mayosmith W W, Dupuy D E. Microwave ablation of lung malignancies:effectiveness, CT findings, and safety in 50 patients[J]. Radiology, 2008, 247(3):871-879.
[6] Liang P, Yu X L, Yu J. Microwave ablation treatment of solid tumors[J]. Anticancer Research, 2015, 35(3):3-14.
[7] Swan R Z, Sindram D, Martinie J B, Iannitti D A. Operative microwave ablation for hepatocellular carcinoma:complications, recurrence, and long-term outcomes[J]. Journal of Gastrointestinal Surgery, 2013, 17(4):719-729.
[8] Pillai K, Akhter J, Chua T C, Shehata M, Alzahrani N, Al-Alem I, Morris D L. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model[J]. Medicine, 2015, 94(9):e580.
[9] Chiang J, Willey B J, Rio A M D, Hinshaw J L, Lee F T, Brace C L. Predictors of thrombosis in hepatic vasculature during microwave tumor ablation of an in vivo porcine model[J]. Journal of Vascular and Interventional Radiology, 2014, 25(12):1965-1971.
[10] Shi H T, Liu T L, Fu C H, Li L L, Tan L F, Wang J Z, Ren X L, Ren J, Wang J X, Meng X W. Insights into a microwave susceptible agent for minimally invasive microwave tumor thermal therapy[J]. Biomaterials, 2015, 44:91-102.
[11] Shi H, Niu M, Tan L, Liu T, Shao H, Fu C, Ren X L, Ma T C, Ren J, Li L L, Liu H Y, Xu K, Wang J X, Tang F Q, Meng X W. A smart all-in-one theranostic platform for CT imaging guided tumor microwave thermotherapy based on IL@ZrO2 nanoparticles[J]. Chemical Science, 2015, 6(8):5016-5026.
[12] Long D, Liu T L, Tan L F, Shi H T, Liang P, Tang S S, Wu Q, Yu J, Dou J P, Meng X W. Multisynergistic platform for tumor therapy by mild microwave irradiation-activated chemotherapy and enhanced ablation[J]. ACS Nano, 2016, 10(10):9516-9528.
[13] Du Q, Fu C H, Tie J, Liu T L, Li L L, Ren X L, Huang Z B, Liu H Y, Tang F Q, Li L, Meng X W. Gelatin microcapsules for enhanced microwave tumor hyperthermia[J]. Nanoscale, 2015, 7:3147-54.
[14] Du Q, Ma T C, Fu C H, Liu T L, Huang Z B, Ren J, Shao H B, Xu K, Tang F Q, Meng X W. Encapsulating ionic liquid and Fe3O4 nanoparticles in gelatin microcapsules as microwave susceptible agent for MR imaging-guided tumor thermotherapy[J]. ACS Applied Materials & Interfaces, 2015, 7:13612-13619.
[15] Kobayashi H, Watanabe R, Choyke P L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?[J]. Theranostics, 2014, 4(1):81-89.
[16] Kamphorst J J, Gottlieb E. Cancer metabolism:friendly neighbours feed tumour cells[J]. Nature, 2016, 536:401-402.
[17] Wang S P, Tan L F, Liang P, Liu T, Wang J Z, Fu C H, Yu J, Dou J P, Li H, Meng X W. Layered MoS2 nanoflowers for microwave thermal therapy[J]. Journal of Materials Chemistry B, 2016, 4(12):2133-2141.
[18] Minardi S, Pandolfi L, Taraballi F, Rosa D E, Yazdi I K, Liu X, Ferrari M, Tasciotti E. PLGA-mesoporous silicon microspheres for the in vivo controlled temporospatial delivery of proteins[J]. ACS Applied Materials & Interfaces, 2015, 7:16364-16373. |